New shot may slash cholesterol right after a heart attack
NCT ID NCT07102628
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether starting inclisiran early during a hospital stay for a heart attack can lower bad cholesterol more than a placebo, when both are added to standard care. About 300 adults hospitalized for a heart attack will receive either inclisiran or a placebo shot at the start and again 90 days later. The main goal is to see if inclisiran leads to greater cholesterol reduction by day 150.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Inclisiran
What this could lead to
If it works, this could provide a new way to quickly lower bad cholesterol after a heart attack, potentially reducing the risk of future heart problems.
What could go wrong
This is still an early Phase 3 trial with 300 participants, so results may not apply to everyone. Inclisiran may not lower cholesterol enough or could have side effects not yet seen.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Novartis Investigative Site
RECRUITINGKiel, 24105, Germany
-
Novartis Investigative Site
RECRUITINGHong Kong, Hong Kong, 999077, Hong Kong
-
Novartis Investigative Site
RECRUITINGHong Kong, 999077, Hong Kong
-
Novartis Investigative Site
RECRUITINGPécs, Baranya, 7623, Hungary
-
Novartis Investigative Site
RECRUITINGDebrecen, Hajdu Bihar Megye, 4032, Hungary
-
Novartis Investigative Site
RECRUITINGBudapest, 1134, Hungary
-
Novartis Investigative Site
RECRUITINGBudapest, H-1083, Hungary
-
Novartis Investigative Site
RECRUITINGMiskolc, 3526, Hungary
-
Novartis Investigative Site
RECRUITINGBelagavi, Karnataka, 590010, India
-
Novartis Investigative Site
RECRUITINGMumbai, Maharashtra, 400012, India
-
Novartis Investigative Site
RECRUITINGNashik, Maharashtra, 422005, India
-
Novartis Investigative Site
RECRUITINGBikaner, Rajasthan, 334003, India
-
Novartis Investigative Site
COMPLETEDChikushino-shi, Fukuka, 818-8516, Japan
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGKitakyushu, Fukuoka, 8028555, Japan
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGKamakura, Kanagawa, 247-8533, Japan
-
Novartis Investigative Site
WITHDRAWNSagamihara, Kanagawa, 252-0375, Japan
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGBunkyo Ku, Tokyo, 1138431, Japan
-
Novartis Investigative Site
RECRUITINGGdansk, 80-214, Poland
-
Novartis Investigative Site
RECRUITINGKatowice, 40-635, Poland
-
Novartis Investigative Site
RECRUITINGKrakow, 31 202, Poland
-
Novartis Investigative Site
RECRUITINGOpole, 45-401, Poland
-
Novartis Investigative Site
RECRUITINGSeoul, Seoul, 06351, South Korea
-
Novartis Investigative Site
RECRUITINGSeoul, 07804, South Korea
-
Novartis Investigative Site
RECRUITINGSantiago Compostela, A Coruna, 15706, Spain
-
Novartis Investigative Site
RECRUITINGHuelva, Andalusia, 21005, Spain
-
Novartis Investigative Site
RECRUITINGEl Palmar, Murcia, 30120, Spain
-
Novartis Investigative Site
RECRUITINGLas Palmas GC, 35010, Spain
-
Novartis Investigative Site
RECRUITINGMadrid, 28034, Spain
-
Novartis Investigative Site
RECRUITINGMadrid, 28046, Spain
-
Novartis Investigative Site
RECRUITINGSalamanca, 37007, Spain
-
Novartis Investigative Site
RECRUITINGSeville, 41013, Spain
-
Novartis Investigative Site
RECRUITINGValencia, 46010, Spain
-
Novartis Investigative Site
RECRUITINGBern, 3010, Switzerland
-
Novartis Investigative Site
RECRUITINGGeneva, 1211, Switzerland
-
Novartis Investigative Site
RECRUITINGLucerne, 6000, Switzerland
-
Novartis Investigative Site
RECRUITINGClayton, Victoria, 3168, Australia
-
Novartis Investigative Site
RECRUITINGMontreal, Quebec, H1T 1C8, Canada
-
Novartis Investigative Site
RECRUITINGQuébec, Quebec, G1V 4G5, Canada
-
Novartis Investigative Site
RECRUITINGBeijing, China, 100037, China
-
Novartis Investigative Site
RECRUITINGGuangzhou, Guangdong, 510080, China
-
Novartis Investigative Site
RECRUITINGLuoyang, Henan, 471002, China
-
Novartis Investigative Site
RECRUITINGXuzhou, Jiangsu, 221003, China
-
Novartis Investigative Site
RECRUITINGNanchang, Jiangxi, 330009, China
-
Novartis Investigative Site
RECRUITINGWenzhou, Zhejiang, 325000, China
-
Novartis Investigative Site
RECRUITINGBeijing, 100191, China
-
Novartis Investigative Site
RECRUITINGBeijing, 100730, China
-
Novartis Investigative Site
RECRUITINGFuzhou, 350001, China
-
Novartis Investigative Site
RECRUITINGGuangzhou, 510260, China
-
Novartis Investigative Site
RECRUITINGGuangzhou, 510280, China
-
Novartis Investigative Site
RECRUITINGJining, 272011, China
-
Novartis Investigative Site
RECRUITINGShanghai, 200032, China
-
Novartis Investigative Site
RECRUITINGShanghai, 200120, China
-
Novartis Investigative Site
RECRUITINGTianjin, 300052, China
-
Novartis Investigative Site
RECRUITINGChambray-lès-Tours, 37170, France
-
Novartis Investigative Site
RECRUITINGMontpellier, 34295, France
-
Novartis Investigative Site
RECRUITINGNantes, 44093, France
-
Novartis Investigative Site
RECRUITINGPessac, 33604, France
-
Novartis Investigative Site
RECRUITINGPoitiers, 86021, France
-
Novartis Investigative Site
RECRUITINGLeipzig, Saxony, 04289, Germany
-
Novartis Investigative Site
RECRUITINGCoburg, 96450, Germany
-
Novartis Investigative Site
RECRUITINGErfurt, 99089, Germany
-
Novartis Investigative Site
RECRUITINGEssen, 45147, Germany
-
Novartis Investigative Site
RECRUITINGHennigsdorf, 16761, Germany